Market Size of Serum Separation Gel Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Serum Separation Gel Market Analysis
The Serum Separation Gel Market studied was anticipated to grow with a CAGR of 4.6% during the forecast period. The major factors attributing to the growth of the market are a rise in the number of blood tests and blood banks to examine state and type of blood. Rising prevalence of Bloodstream infections diseases like nosocomial candidemia has increased the demand for the products. For instance, as per the study report published by the National Center for Biotechnology in 2019, nosocomial candidemia is the most common bloodstream infection, associated with significant morbidity and mortality across the globe. Also, a rise in awareness among the public about infectious disease diagnosis is expected to result in a greater number of new examinations propelling the serum separation gel market.
Serum Separation Gel Industry Segmentation
Serum separation gels are substances used to separate a blood clot and serum with higher stability and reliability to minimize the influence on clinical test results. These are mostly available in the form of serum separation tubes (SSTs) used for collecting blood samples in clinical chemistry assays.
| Product Type | |
| Serum Separation Gel Integrated with Tube | |
| Serum Separation Gel without Tubes |
| End-Users | |
| Hospital | |
| Blood Bank | |
| Pharmaceutical & Biotechnology Companies | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Serum Separation Gel Market Size Summary
The serum separation gel market is poised for steady growth, driven by an increasing number of blood tests and the rising prevalence of bloodstream infections such as nosocomial candidemia. This demand is further fueled by heightened public awareness regarding infectious disease diagnosis, leading to more frequent examinations. The market is characterized by the integration of serum separation gels with tubes, which are gaining traction in clinical research within pathological sciences. These tubes offer enhanced convenience, improved sample handling, and advantages like higher resistance to irradiation and lower interference in clinical test results, contributing to their dominance in the industry.
Regionally, North America is expected to maintain its leadership in the global serum separation gels market, largely due to a significant rise in hematological disorders and infectious diseases, particularly among the elderly population. The United States, with its large baby boomer demographic, leads in market revenue, supported by favorable co-pay systems and advanced blood bank infrastructure. The market is moderately competitive, with major players like Cardinal Health Inc, IntervacTechnology, and Becton Dickinson & Company actively engaging in product launches and strategic mergers to strengthen their global presence. The ongoing preference for digital healthcare services further bolsters the market's growth trajectory.
Serum Separation Gel Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Global Prevalence of Infections and Rise in Geriatric Population
-
1.2.2 Increased Number of Contract Research Oragnisations in the Biotechnology Industry
-
-
1.3 Market Restraints
-
1.3.1 Highly Expensive Serum Separation Gel Tubes
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Product Type
-
2.1.1 Serum Separation Gel Integrated with Tube
-
2.1.2 Serum Separation Gel without Tubes
-
-
2.2 End-Users
-
2.2.1 Hospital
-
2.2.2 Blood Bank
-
2.2.3 Pharmaceutical & Biotechnology Companies
-
2.2.4 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Serum Separation Gel Market Size FAQs
What is the current Serum Separation Gel Market size?
The Serum Separation Gel Market is projected to register a CAGR of 4.60% during the forecast period (2024-2029)
Who are the key players in Serum Separation Gel Market?
cardinal Health, Inc., InterVacTechnology OU, Becton Dickinson & Company and Greiner Bio One International GmbH are the major companies operating in the Serum Separation Gel Market.
